SCHEMBL29409733

SCHEMBL29409733

CN([11CH3])c1ccc(/C=C/C=C/c2nc3ccccc3s2)cc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.84
▸ KMT2A Q03164 7/20 0.84
▸ MAPT P10636 6/20 0.84
▸ APP P05067 6/20 0.84
▸ RAB9A P51151 6/20 0.84
▸ SMN1; SMN2 Q16637 3/20 0.84
▸ INSR P06213 3/20 0.84
▸ NCOA1 Q15788 1/20 0.84
▸ NPC1 O15118 3/20 0.62
▸ NPSR1 Q6W5P4 2/20 0.62
▸ CYP1A2 P05177 1/20 0.62
▸ CYP3A4 P08684 1/20 0.62
▸ CYP2D6 P10635 1/20 0.62
▸ CYP2C19 P33261 1/20 0.62
▸ L3MBTL1 Q9Y468 4/20 0.54
▸ LMNA P02545 2/20 0.54
▸ KAT8 Q9H7Z6 1/20 0.50
▸ SNCA P37840 1/20 0.49
▸ MAPK1 P28482 2/20 0.49
▸ HTT P42858 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9841114 1.00 MEN1 (0.84) MEN1KMT2AMAPTAPPRAB9A
SCHEMBL9841113 1.00 MEN1 (0.84) MEN1KMT2AMAPTAPPRAB9A
SCHEMBL31447671 1.00 MEN1 (0.84) MEN1KMT2AMAPTAPPRAB9A
SCHEMBL476579 0.92 MEN1 (1.00) MEN1KMT2AMAPTAPPRAB9A
SCHEMBL29433017 0.92 MEN1 (1.00) MEN1KMT2AMAPTAPPRAB9A
SCHEMBL29413750 0.92 MEN1 (1.00) MEN1KMT2AMAPTAPPRAB9A
SCHEMBL476578 0.92 MEN1 (1.00) MEN1KMT2AMAPTAPPRAB9A
Bromide SCHEMBL8389953 0.90 MEN1 (0.97) MEN1KMT2AMAPTAPPRAB9A
Bromide SCHEMBL8389954 0.90 MEN1 (0.97) MEN1KMT2AMAPTAPPRAB9A
Iodide SCHEMBL8390905 0.90 MEN1 (0.97) MEN1KMT2AMAPTAPPRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250340547-A1 NOVEL COMPOUNDS FOR IMAGING TAU PROTEINS THAT ACCUMULATE IN THE BRAIN NATIONAL INSTITUTES FOR QUANTUM AND RADIOLOGICAL SCIENCE AND TECHNOLOGY (JP) 2025-11-06 — — US disclosed
US-12195454-B2 Compounds for imaging tau proteins that accumulate in the brain NATIONAL INSTITUTES FOR QUANTUM AND RADIOLOGICAL SCIENCE AND TECHNOLOGY (JP) 2025-01-14 — — US disclosed
US-20240083893-A1 COMPOUNDS FOR IMAGING TAU PROTEINS THAT ACCUMULATE IN THE BRAIN NATIONAL INSTITUTES FOR QUANTUM AND RADIOLOGICAL SCIENCE AND TECHNOLOGY (JP) 2024-03-14 — — US disclosed
US-11667628-B2 Compounds for imaging tau proteins that accumulate in brain NATIONAL INSTITUTES FOR QUANTUM AND RADIOLOGICAL SCIENCE AND TECHNOLOGY (JP) 2023-06-06 — — US disclosed
US-20220056020-A1 NOVEL COMPOUNDS FOR IMAGING TAU PROTEINS THAT ACCUMULATE IN BRAIN NATIONAL INSTITUTES FOR QUANTUM AND RADIOLOGICAL SCIENCE AND TECHNOLOGY (JP) 2022-02-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240083893-A1 COMPOUNDS FOR IMAGING TAU PROTEINS THAT ACCUMULATE IN THE BRAIN MAPT, FABP7, HTT MEN1 4010/4885KMT2A 2213/4885MAPT 1/4885
US-12195454-B2 Compounds for imaging tau proteins that accumulate in the brain MAPT, FABP7, HTT MEN1 4010/4885KMT2A 2213/4885MAPT 1/4885
US-11667628-B2 Compounds for imaging tau proteins that accumulate in brain MAPT, FABP7, HTT MEN1 3842/4885KMT2A 2585/4885MAPT 1/4885
US-20220056020-A1 NOVEL COMPOUNDS FOR IMAGING TAU PROTEINS THAT ACCUMULATE IN BRAIN MAPT, FABP7, HTT MEN1 4174/4885KMT2A 2340/4885MAPT 1/4885
US-20250340547-A1 NOVEL COMPOUNDS FOR IMAGING TAU PROTEINS THAT ACCUMULATE IN THE BRAIN MAPT, FABP7, HTT MEN1 4288/4885KMT2A 2880/4885MAPT 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback